During the past decade, National Cancer Center Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 2 clinical trials were completed. i.e. 10.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Cancer Center Hospital" #1 sponsor was "Boehringer Ingelheim" with 15 trials, followed by "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Seagen Inc." with 3 trials sponsored, "Ariad Pharmaceuticals" with 1 trials sponsored and "Calico Life Sciences LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Center Hospital" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Eisai Co., Ltd." with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Center Hospital" are "Neoplasms" (5 trials), "Solid Tumors" (3 trials), "Breast Neoplasms" (2 trials), "Solid Tumors, KRAS Mutation" (2 trials) and "Advanced Solid Tumors Cancer" (1 trials). Many other conditions were trialed in "National Cancer Center Hospital" in a lesser frequency.

Most popular intervention types in "National Cancer Center Hospital" are "Drug" (26 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "BI 754091" (4 trials), "BI 907828" (4 trials), "trastuzumab" (3 trials), "tucatinib" (3 trials) and "BI 3011441" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Center Hospital" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "National Cancer Center Hospital". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in National Cancer Center Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Center Hospital, 13 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".